학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 61건 | 목록 1~10
Academic Journal
Ferguson KM; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.; Gillen SL; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.; Chaytor L; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.; Poon E; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.; Marcos D; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.; Gomez RL; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Healthcare City, P.O. Box 505055, Dubai, United Arab Emirates.; Woods LM; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.; Mykhaylechko L; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.; Elfari L; Wellcome-MRC Cambridge Stem Cell Institute Advanced Imaging Facility, Cambridge CB2 0AW, UK.; Martins da Costa B; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.; Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.; Ali FR; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Healthcare City, P.O. Box 505055, Dubai, United Arab Emirates.; Philpott A; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK. Electronic address: ap113@cam.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 101120028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1551 (Electronic) Linking ISSN: 15345807 NLM ISO Abbreviation: Dev Cell Subsets: MEDLINE
Academic Journal
Reeves EL; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Li J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Zormpas-Petridis K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Boult JKR; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Sullivan J; Royal Marsden NHS Foundation Trust, London, UK.; Cummings C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Blouw B; Halozyme Therapeutics, San Diego, CA, USA.; Kang D; Halozyme Therapeutics, San Diego, CA, USA.; Sinkus R; Division of Imaging Sciences and Biomedical Engineering, King's College London, UK.; Bamber JC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Tucker ER; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Jiménez I; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Chen L; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom.; Bellini A; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Gorrini C; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Calton E; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Gao Q; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Che H; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Poon E; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Martins Da Costa B; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Barker K; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Shrestha S; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Hutchinson JC; Department of Histopathology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.; Dhariwal S; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom.; Goodman A; Newcastle Genetics Laboratory, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.; Del Nery E; Department of Translational Research, The Biophenics High-Content Screening Laboratory, PSL Research University, PICT-IBiSa, Institut Curie Research Center, Paris, France.; Gestraud P; Bioinformatics platform, INSERM U900, PSL Research University, Institut Curie Research Center, Paris, France.; Bhalshankar J; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Iddir Y; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Saberi-Ansari E; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Saint-Charles A; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; Marques Da Costa ME; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.; Pierre-Eugène C; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Janoueix-Lerosey I; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France.; Nemati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France.; Carcaboso AM; Hospital Sant Joan de Déu, Barcelona, Spain.; Surdez D; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; Balgrist University Hospital, Faculty of Medicine, University of Zurich (UZH), Zurich, Switzerland.; Delattre O; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.; George SL; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Chesler L; Pediatric Tumour Biology and Therapeutics Team, Centre for Paediatric Oncology Experimental Medicine, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Tweddle DA; Wolfson Childhood Cancer Research Centre, Translational & Clinical Research Institute, Newcastle Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom.; Schleiermacher G; SiRIC RTOP (Recherche Translationelle en Oncologie Pédiatrique), Translational Research Department, Institut Curie Research Center, PSL Research University, Institut Curie, Paris, France.; INSERM U830, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Institut Curie Research Center, Paris, France.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
King D; Academic Unit of Molecular Oncology, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Li XD; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Present address: Medical Research Council Cancer Unit, Hutchison/Medical Research Council Research Centre, University of Cambridge, Cambridge, UK.; Almeida GS; Divisions of Radiotherapy & Imaging, The Institute of Cancer Research, Sutton, UK.; The Children and Young People's Unit, The Royal Marsden NHS Trust, Sutton, UK.; Kwok C; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Gravells P; Academic Unit of Molecular Oncology, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Harrison D; Academic Unit of Molecular Oncology, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Burke S; Academic Unit of Molecular Oncology, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Hallsworth A; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Jamin Y; Divisions of Radiotherapy & Imaging, The Institute of Cancer Research, Sutton, UK.; The Children and Young People's Unit, The Royal Marsden NHS Trust, Sutton, UK.; George S; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Robinson SP; Divisions of Radiotherapy & Imaging, The Institute of Cancer Research, Sutton, UK.; The Children and Young People's Unit, The Royal Marsden NHS Trust, Sutton, UK.; Lord CJ; CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.; Poon E; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Yeomanson D; Sheffield Children's Hospital, Western Bank, Sheffield, UK.; Chesler L; Divisions of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Bryant HE; Academic Unit of Molecular Oncology, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Parasaram V; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.; Civale J; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.; Bamber JC; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.; Robinson SP; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.; Jamin Y; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.; Harris E; Division of Radiotherapy and Imaging, Centre for Cancer Imaging, Institute of Cancer Research, London SM2 5NG, UK.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Nijhuis A; Department of Surgery & Cancer, Imperial College London, London, UK.; Sikka A; Department of Surgery & Cancer, Imperial College London, London, UK.; Yogev O; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Herendi L; Department of Surgery & Cancer, Imperial College London, London, UK.; Balcells C; Department of Surgery & Cancer, Imperial College London, London, UK.; Ma Y; Department of Surgery & Cancer, Imperial College London, London, UK.; Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Eckold C; Department of Surgery & Cancer, Imperial College London, London, UK.; Valbuena GN; Department of Surgery & Cancer, Imperial College London, London, UK.; Xu Y; Department of Surgery & Cancer, Imperial College London, London, UK.; Liu Y; Department of Surgery & Cancer, Imperial College London, London, UK.; da Costa BM; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Gruet M; Department of Surgery & Cancer, Imperial College London, London, UK.; Wickremesinghe C; Department of Surgery & Cancer, Imperial College London, London, UK.; Benito A; Department of Surgery & Cancer, Imperial College London, London, UK.; Kramer H; Medical Research Council London Institute of Medical Science, London, UK.; Montoya A; Medical Research Council London Institute of Medical Science, London, UK.; Carling D; Medical Research Council London Institute of Medical Science, London, UK.; Want EJ; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and Royal Marsden NHS Trust, London, UK.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Keun HC; Department of Surgery & Cancer, Imperial College London, London, UK. h.keun@imperial.ac.uk.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. h.keun@imperial.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Dubiella C; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel.; Pinch BJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Chemistry and Chemical Biology, Department of Chemical Biology, Harvard University, Cambridge, MA, USA.; Koikawa K; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Zaidman D; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel.; Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Manz TD; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Department of Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbruecken, Germany.; Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; He S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Resnick E; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel.; Rogel A; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel.; Langer EM; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Daniel CJ; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Seo HS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chen Y; College of Chemistry and Molecular Engineering, Peking University, Beijing, China.; Adelmant G; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Sharifzadeh S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Martins da Costa B; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Zimmerman MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Lian X; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kibe S; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kozono S; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Doctor ZM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Browne CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Boston, MA, USA.; Yang A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stoler-Barak L; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.; Shah RB; Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Cell, Developmental and Regenerative Biology, The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Vangos NE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Geffken EA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Oren R; Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel.; Koide E; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Sidi S; Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Cell, Developmental and Regenerative Biology, The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Shulman Z; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.; Wang C; College of Chemistry and Molecular Engineering, Peking University, Beijing, China.; Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Dhe-Paganon S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Look T; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Division of Pediatric Hematology/Oncology Boston Children's Hospital, Boston, MA, USA.; Zhou XZ; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lu KP; Department of Medicine, Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sears RC; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR, USA.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nsgray01@stanford.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nsgray01@stanford.edu.; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA. nsgray01@stanford.edu.; London N; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel. nir.london@weizmann.ac.il.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE
Academic Journal
Zormpas-Petridis K; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Tunariu N; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Curcean A; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Messiou C; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Curcean S; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Collins DJ; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Hughes JC; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Jamin Y; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Koh DM; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).; Blackledge MD; Division of Radiation Therapy and Imaging, The Institute of Cancer Research, 123 Old Brompton Rd, London SW7 3RP, England (K.Z.P., N.T., A.C., C.M., S.C., D.J.C., J.C.H., Y.J., D.M.K., M.D.B.); and Department of Radiology, The Royal Marsden National Health Service Foundation Trust, Surrey, England (N.T., A.C., C.M., S.C., J.C.H., D.M.K.).
Publisher: Radiological Society of North America, Inc Country of Publication: United States NLM ID: 101746556 Publication Model: eCollection Cited Medium: Internet ISSN: 2638-6100 (Electronic) Linking ISSN: 26386100 NLM ISO Abbreviation: Radiol Artif Intell Subsets: PubMed not MEDLINE
Academic Journal
Roeschert I; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.; Poon E; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, The Royal Marsden NHS Trust, 15 Cotswold Rd. Belmont, Sutton, Surrey SM2 5NG, UK.; Henssen AG; Experimental and Clinical Research Center, Max Delbrück Center and Charité Berlin, Lindenberger Weg 80, 13125 Berlin, Germany.; Garcia HD; Experimental and Clinical Research Center, Max Delbrück Center and Charité Berlin, Lindenberger Weg 80, 13125 Berlin, Germany.; Gatti M; Department of Molecular Mechanisms of Disease, University of Zurich, Winterthurerstraße 190, 8057 Zurich, Switzerland.; Giansanti C; Institute of Molecular Oncology, Center of Molecular Biosciences, University of Göttingen, Justus von Liebig Weg 11, 37077 Göttingen, Germany.; Jamin Y; Divisions of Radiotherapy and Imaging, The Institute of Cancer Research, The Royal Marsden NHS Trust, 15 Cotswold Rd. Belmont, Sutton, Surrey SM2 5NG, UK.; Ade CP; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.; Gallant P; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.; Schülein-Völk C; Theodor Boveri Institute, Core Unit High-Content Microscopy, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.; Beli P; Institute of Molecular Biology, Ackermannweg 4, 55128 Mainz, Germany.; Richards M; Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.; Rosenfeldt M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Josef-Schneider-Str. 6, 97080 Würzburg, Germany.; Altmeyer M; Department of Molecular Mechanisms of Disease, University of Zurich, Winterthurerstraße 190, 8057 Zurich, Switzerland.; Anderson J; UCL Great Ormond Street Institute of Child Health, 30 Guilford Street London WC1N 1EH, UK.; Eggert A; Experimental and Clinical Research Center, Max Delbrück Center and Charité Berlin, Lindenberger Weg 80, 13125 Berlin, Germany.; Dobbelstein M; Institute of Molecular Oncology, Center of Molecular Biosciences, University of Göttingen, Justus von Liebig Weg 11, 37077 Göttingen, Germany.; Bayliss R; Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.; Chesler L; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, The Royal Marsden NHS Trust, 15 Cotswold Rd. Belmont, Sutton, Surrey SM2 5NG, UK.; Büchel G; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.; Mildred Scheel Early Career Center, University Hospital Würzburg, Josef-Schneider-Str. 6, 97080 Würzburg, Germany.; Eilers M; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer
Academic Journal
Zormpas-Petridis K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Noguera R; Department of Pathology, Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.; Low Prevalence Tumors, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Ivankovic DK; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Roxanis I; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.; Yuan Y; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Jamin Y
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어